Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cytori Therapeutics reports topline data from STAR trial in scleroderma

July 25, 2017

TRPA1 involved in inflammation in arthritis can be inhibited by dexamethasone and aurothiomalate

July 25, 2017

Chugai Pharmaceutical presents antibodies for treating muscle wasting

July 18, 2017

Blockade of G-CSF receptor found to improve arthritic pain in mice

July 18, 2017

GSK initiates phase II study of GSK-2330811 in diffuse cutaneous systemic sclerosis

July 13, 2017

Korea first to approve Invossa-K cell and gene therapy for degenerative arthritis

July 13, 2017

Nektar Therapeutics describes activity of autoimmune disease candidate NKTR-358

July 12, 2017

FDA designates tadekinig alfa an orphan treatment for Still's disease

July 10, 2017

Sirukumab named orphan drug in the U.S. for juvenile idiopathic arthritis

July 10, 2017

Padlock Therapeutics patents protein-arginine deiminase type-4 inhibitors

July 7, 2017

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...